that the only reason these guys were willing to pay significantly over the market price is they were signed as insiders and shown results to date. I do not believe anyone would pay such a premium to our share price, with the long delays in assays and the little amount of assays we do have without getting a good peak at the results to date. This is a very legal thing to do for the company with the proper insider disclosure and speaks volume about our pending results.

Great things to come in 2011!

Also, a big congrats to our CEO, Frank Candido and our BoD, I have never seen a PP done at a premium to the share price. I mean the flow thru was done at over 50% premium to the share price WOW!! Never seen anything like that before.

Glorieux